Harrison P. Nguyen on Muck Rack

Harrison P. Nguyen

Houston
As seen in: Frontiers, JAMA Dermatology, CSIRO Publishing, HCP Live, HMP Global Learning Network, Journal of The American Academy of Dermatology (JAAD), Dermatology Times, 2 Minute Medicine, SKIN The Journal of Cutaneous Medicine, JAAD International
Managing Director @Houston_Skin | Clinical Investigator and Co-Fellowship Director @CCS_Texas
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Harrison P.

Contact Harrison P., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Individualizing Treatment Selection in Atopic Dermatitis, With Harrison Nguyen, MD, MBA, MPH

|
By Harrison P. Nguyen
| consultantlive.com
Nguyen urges clinicians to consider patient's disease presentation, comorbidities, treatment goals, and preferences when making therapeutic decisions.
Open in Who Shared View Duplicates (2) Issue with article?

Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH

|
By Harrison P. Nguyen
| consultantlive.com
Harrison Nguyen, MD, MBA, MPH, founder of Harrison Dermatology & Research Group in Houston, Texas, spoke with HCPLive about the inccreasing complexity, and level of opportunity, within the atopic dermatitis treatment space, following his session titled “Medical Crossfire” at the Revolutionizing Atopic Dermatitis (RAD) Conference 2026 in Nashville, Tennessee.1 Speaking with the editorial team, Nguyen described the modern era of treatment as a “golden revolution” in atopic dermatitis care.
Open in Who Shared View Duplicates (2) Issue with article?

The Cost of Delay: How Prior Authorization Is Impacting Dermatology

|
By Harrison P. Nguyen, Shannon C. Trotter, Matthew Zirwas
| consultantlive.com
In the world of dermatology today, clinicians have access to an unprecedented array of biologics and targeted treatments designed to dramatically improving outcomes for individuals living with chronic inflammatory skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa (HS).1,2 However, according to 3 dermatologists interviewed by HCPLive, gaining patients access to these drugs has evolved into a more and more complicated procedure.
Open in Who Shared View Duplicates (2) Issue with article?
See all 73 licensed articles (152 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified